Raul Saraiva MSc, PhD

Raul G. Saraiva serves as the Chief Scientific Officer and a Venture Partner at 3xP Global, where he oversees the firm’s health and life sciences vertical. With a background in life sciences venture capital, including positions at Apple Tree Partners (London, United Kingdom) and Portugal Ventures (Porto, Portugal), he has participated in numerous investment deals both within Portugal and overseas, such as CellmAbs and Aethon Therapeutics. He has previously held board-level positions in nine biotech companies in different stages of development. Additionally, he has served in operational roles in nascent startups as part of venture-building exercises. Raul holds a PhD in Molecular Microbiology and Immunology from Johns Hopkins University, and also trained in biochemistry for his BSc and MSc at Universidade do Porto.